Harrow Partners with Cencora to Launch “Harrow Cares” Program
Harrow announced the launch of its “Harrow Cares” program through a strategic partnership with Cencora.
Harrow Cares is designed to deliver a suite of access and affordability services, enhancing support for retina specialists, their staff, and patients. Through a patient support services hub, Harrow Cares aims to provide seamless enrollment, rapid access to therapy, and personalized support, enabling retina providers to confidently utilize Iheezo and Triesence in their practices.
“We are thrilled to collaborate with Cencora on the launch of our ‘Harrow Cares’ program. This partnership reflects our shared commitment to addressing one of the most critical challenges in healthcare–ensuring that life‑changing medications are both accessible and affordable ... This milestone highlights our strategic focus on expanding and solidifying Harrow’s presence in the U.S. retina market, a key area of growth and innovation for our company," Mark L. Baum, Chief Executive Officer of Harrow, said in a company news release.
According to Harrow, features of the Harrow Cares program include:
- Streamlined Enrollment: Providers can enroll via multiple channels, including phone, a dedicated provider portal, or PXConnect technology integration
- Rapid Access to Therapy: Services provide real-time benefit verifications, enabling retina specialists to quickly verify patient benefits and secure timely access to treatment
- Flexible Affordability: Includes an in-house commercial copay assistance program, patient assistance options, and referrals to third-party charitable foundations, allowing patients to pay as little as $0
- Assurance and Ongoing Support: Additional features include patient welcome calls, annual reverification support, escalation for prior authorization denials, and assurance through product replacement programs